THYMIDINE KINASE AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY OR HORMONOTHERAPY IN BREAST-CANCER

被引：0

作者：

BENNINI, N ^{[1
]}

MAURIAC, L ^{[1
]}

WAFFLART, J ^{[1
]}

BONICHON, F ^{[1
]}

DURAND, M ^{[1
]}

机构：

[1] FDN BERGONIE,180 RUE ST GENES,F-33076 BORDEAUX,FRANCE

来源：

BULLETIN DU CANCER | 1992年 / 79卷 / 08期

关键词：

THYMIDINE KINASE; BREAST CANCER; CHEMOTHERAPY; HORMONOTHERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thymidine kinase (TK) was assayed in the cytosol of 210 primary breast cancers to assess its predictive value for response to first line chemotherapy and hormonotherapy. We performed correlations between TK and the other prognosis factors of breast cancer. TK activity is correlated with SBR grading and estrogen receptors. It has a low predictive value for response to chemotherapy and is not useful for hormonotherapy.

引用

页码：773 / 779

页数：7

共 19 条

[1]

CHAUVERGNE J, 1988, NEOADJUVANT CHEMOTHE, P225

[2]

DRESSLER LG, 1988, CANCER, V61, P420, DOI 10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO

[3]

2-0

[4]

GALLOUX H, 1988, CR ACAD SCI III-VIE, V306, P89

[5]

GERDES J, 1987, AM J PATHOL, V129, P486

[6]

GOING JJ, 1988, AM J PATHOL, V130, P193

[7]

JACQUEMIER J, 1981, EVALUATION MOYENS DI, P173

[8]

JAVRE JL, 1986, B CANCER, V73, P8

[9]

MADEC A, 1988, B CANCER, V75, P187

[10]

MAGDELENAT H, 1980, 2E JOURN SOC FRANC S, P107

← 1 2 →